Actinobacillus actinomycetemcomitans is a Gram-negative bacterium implicated in the pathology of localized juvenile periodontitis, a condition involving rapid destruction of alveolar bone. We have established that gentle extraction of this bacterium in saline releases a proteinaceous fraction (which we have termed surface-associated material [SAM]) which has potent osteolytic activity in the murine calvarial bone resorption assay. Fractionation of the SAM has now revealed that activity is associated with a 62-kD protein. This bone-resorbing activity can be blocked by a monoclonal antibody (raised to the whole bacterium) that is claimed to recognize a protein homologous to the Escherichia coil molecular chaperone GroEL. Purification of this bone-resorbing protein to homogeneity has been achieved by a combination of anion exchange, gel filtration, and ATP-affinity chromatography and the NH2-terminal sequence shows > 95% homology to E.
Introduction
The chronic inflammatory periodontal diseases (CIPDs)' are humans. They are characterized by inflammation of the gingivae and the resorption of the alveolar bone supporting the teeth, a process which can lead to tooth loss. Evidence strongly suggests that the presence of certain Gram-negative oral bacteria in periodontal pockets (which are formed between the gum and the tooth in this disease) is a major factor in the development of tissue pathology, and this relationship has been best documented with the bacterium Actinobacillus actinomycetemcomitans and its role in localized juvenile periodontitis (LJP) (1, 2) . However, the precise mechanisms responsible for the resorption of alveolar bone in this disease remain to be established. Bacteria may invade the periodontal tissues (3) , but the accepted paradigm is that the resorption mechanism involves factors released by the bacteria, which either directly stimulate bone breakdown or generate the synthesis and/or release of osteolytic mediators within host tissues (3, 4) . These mediators may include prostanoids and/or certain proinflammatory cytokines such as IL-1 and TNFa, all of which have potent osteolytic activity.
Using a simple saline extraction procedure we have isolated a fraction from the surface (termed surface-associated material [SAM] ) of a number of bacteria implicated in the pathology of the CIPDs. This fraction contains the capsule and other components loosely associated with the outer membrane of the bacteria, and electron microscopic examination of extracted organisms demonstrates the removal of extracellular material but fails to show evidence of cell lysis (5, 6 ). In the case ofA. actinomycetemcomitans this highly soluble fraction consists largely of protein (> 60%) and an extremely small amount of LPS (6) . There is now evidence that the SAM is shed by oral bacteria in situ, being found on the tooth roots of extracted teeth from patients with CIPD (7). The SAM from A. actinomycetemcomitans, has a number of biological activities including inhibition of cellular proliferation (8) and of collagen synthesis (9) . However, its most potent action is the stimulation of murine calvarial bone breakdown, with activity being seen at concentrations as low as 1 ng/ml (5, 6) . In this assay the SAM is 10-100 times more potent than the LPS prepared from the same organism (5) . Thus, the active moiety in this fraction could be a major factor in the pathogenesis of bone resorption in LJP. A number of bacterial components including LPS, teichoic acids, muramyl dipeptide, and certain protein fractions have been shown to be capable of stimulating bone resorption (10) (11) (12) (13) . However, with the possible exception of a toxin from the bacterium Pasteurella multocida (14) , the SAM from A. actinomycetemcomitans is the most potent bacterial osteolytic agent reported. As described in this paper we have established that the active moiety is a 62-kD protein and thus its molar potency is in the picomolar range, similar to that reported for potent osteolytic cytokines such as IL-1 or TNF.
We have now isolated this osteolytic protein by use of anion exchange, gel filtration, and affinity chromatography and have determined its NH2-terminal sequence. Care has been taken to exclude the possibility that LPS is contributing to the osteolytic activity of this protein. Isolation was aided by the use of monoclonal antibodies which neutralize the bone-resorbing activity of the SAM. These SDS-PAGE. The components of the SAM were analyzed by SDS-PAGE using 12% gels according to the method of Laemmli (21). Samples were diluted 1:1 with sample buffer and boiled for 5 min before loading. Gels were run using a MiniProtean I system (Bio Rad Laboratories) and stained with Coomassie brilliant blue (Sigma Immunochemicals). The molecular weight markers used were Dalton VIIL (Sigma Immunochemicals). Gels were also silver stained using a commercial kit (Gelcode@ silver stain kit; Pierce, Rockford, IL) to detect both the presence of protein and carbohydrate.
Two-dimensional PAGE. Two-dimensional PAGE gels were run according to the method of O'Farrell (22) . Gels were run using a MiniProtean II system and stained with Coomassie blue, with similar molecular weight markers as above. The first dimension, isoelectric focusing, was over the pI range of 3-10. Second dimension separation was by molecular mass using a 12% SDS-PAGE gel.
Immunoblotting. Samples separated on one-or two-dimensional Protein purification. Crude SAM was fractionated at 40C on a QSepharose anion exchange column (50 cm X 1.6 cm). The column was equilibrated in 20 mM Tris-HCI, pH 8.5 (buffer A), and the SAM (generally 100-400 mg) was loaded on in the same buffer. The column was washed with 500 ml of buffer A and then eluted with a 1,000-ml linear gradient of 0-2 M NaCl in buffer A. 10-ml fractions were collected, and the absorbance at 280 nm was monitored. The location of the osteolytic protein was determined by a combination of activity assay, SDS-PAGE, and Western blot analysis. Fractions containing osteolytic activity were dialyzed against deionized water to remove salt and lyophilized. The fraction with the highest specific activity and the least number of protein bands on SDS-PAGE was then further fractionated at room temperature on a second anion exchange column. There was some evidence of proteolytic clipping of the 62-kD protein and so aliquots of this fraction were dissolved at 1 mg/ml in 20 mM Tris, pH 7.2, containing proteinase inhibitors (1 mM PMSF, 1 mM EDTA, and 1 mM benzamidine) (buffer B) and fractionated on an EconoPak Q column (Bio Rad Laboratories) equilibrated in buffer B. Fractions were eluted by application of a gradient of 0-1.5 M NaCl in buffer B, and an absorbance profile at 280 nm was obtained. Fractions were again analyzed for osteolytic activity and Western immunoblotted with mAb P3 to confirm the presence of the immunogenic 62-kD protein. The purity of the fractions was again assessed visually by SDS-PAGE, and 100 Ig of the cleanest fraction was dialyzed against 50 mM of Tris buffer, pH 7.6, containing 10 mM KC1 and 10 mM MgCl2 (buffer C). This sample was run on a 5-ml ATP-Sepharose (Sigma Immunochemicals) column. The column was washed with 10 column volumes of buffer C and bound protein eluted in 5 column volumes of 5 mM ATP (Sigma Immunochemicals), also in buffer C. Protein was located by SDS-PAGE and visualized using a silver stain kit (Sigma Immunochemicals). Gel filtration was used to determine the molecular mass range of the osteolytic protein isolated by ATP-affinity chromatography. This was done by running the purified protein on a Bio-Sil TSK250 (Bio Rad Laboratories) column in 0.1 M sodium phosphate buffer, pH 6.7, and measuring absorption at 205/280 nm.
Immunoaffinity purification. Affinity columns were prepared using mAb P2, mAb P3, and both P2 and P3 together. Briefly, in each case, 5 mg of antibody was linked to 3.5 ml of swollen cyanogen bromideactivated Sepharose 4B (Sigma Immunochemicals) in bicarbonate buffer at pH 8.3. After washing, the column was blocked with 1 M ethanolamine at pH 8.0, washed, and equilibrated in PBS. Crude SAM (5 mg) dissolved at 1 mg/ml in PBS was loaded on, the column was washed extensively, and bound protein was eluted using 0.1 M glycine, pH 2.5. Eluted fractions of 1 ml were concentrated by using Minicon microconcentrators with cutoff membranes of 10 kD (Amicon, Inc., Beverly, MA), to a volume of -50 ,1. These were analyzed by SDS-PAGE and immunoblotting and tested for osteolytic activity in the calvarial bone resorption assay.
Protein sequencing. Material eluting from the ATP-Sepharose column was run on a 10% SDS-PAGE gel according to the method of Laemmli (21) 
Results
Composition of the SAM. The composition of the SAM from the various bacteria is shown in Table I . The SAM from A. actinomycetemcomitans when analyzed by two-dimensional PAGE demonstrated the presence of 50 Coomassie bluestaining spots in the pI range of 3-10 and of molecular masses ranging from < 14 to > 66 kD (Fig. 1) .
Activity of SAM in the murine calvarial bone resorption assay. The SAM extracted from A. actinomycetemcomitans showed a consistent profile of activity ( Fig. 2) with calcium release increasing linearly over the concentration range from 0.01 to 10 jg/ml. With some batches of SAM, significant bone resorbing activity was found at a concentration of 1 ng/ml.
Q-Sepharose anion-exchange chromatography. Osteolytic activity was seen to elute at a salt concentration in the range of 0.9-0.92 M in four consecutive fractions (28-31) (Fig.   3 ). These bioactive fractions represented 3% of the protein applied to the column. Active fractions contained a prominent 62-kD protein band on SDS-PAGE stained with Coomassie blue. Neutralization of bone resorption by mAbs to A. actinomycetemcomitans. mAbs raised to whole A. actinomycetemcomitans were tested in the bone resorption assay to determine if they would have any effect on bone breakdown induced by SAM. The inclusion of nonspecific mouse IgG or mAbs PI or A5 had no noticeable effect on the bone resorbing activity of the SAM, even at concentrations as high as 100 ,tg/ml. In contrast, mAbs P2 and P3 inhibited calcium release. P3 completely inhibited the bone resorbing activity of the SAM when added at a concentration of 7 pg/ml (Fig. 4) , whereas P2 only attained comparable inhibition at a concentration of 100 jsg/ml.
The antibodies had no effect on the bone resorption induced by the osteolytic agonist PGE2. To confirm that antibody-mediated inhibition of bone resorption was associated with binding to components of the SAM, this material was incubated with antibody P3, and the antibody-antigen complexes produced were immunoprecipitated with heat-killed/formalin-fixed S. aureus (Sigma Immunochemicals). It was clear ( .ig/ml ml to 10 ,g/ml.
antibody, reduced the osteolytic activity of A. actinomycetemcomitans SAM to background levels. This was seen to be the case even when the depleted fraction was added at a concentration of 10 Atg/ml. Controls in which SAM was incubated with a nonspecific antibody, or with S. aureus alone, retained activity equal to the untreated SAM. Specificity ofmAbs P2 and P3 assessed by Western blotting. Using two-dimensional SDS-PAGE of A. actinomycetemcomitans SAM, many proteins or protein subunits were separated (Fig. 6 a) . Immunoblotting these preparations using mAbs P2, P3 (Fig. 6 b) , or a combination of both showed that both mAbs recognized the same protein, which had a molecular mass of 62 kD.
Affinity purification ofthe 62-kD osteolytic protein. Affinity columns containing mAbs P2, P3, or a combination of both antibodies, linked to Sepharose 4B, were used to try and achieve a one-pass purification of the active protein. Both In a prior study a small quantity of the 62-kD protein which bound to antibody P3 was used for sequencing. This suggested homology with the E. coli heat shock protein GroEL (24) . It had been demonstrated that purification of this molecular chaperone can be achieved simply by affinity purification on an ATP column (25) . When the anion exchange chromatographypurified fractions containing bone-resorbing activity were passed through an ATP-Sepharose column and the column was washed and then eluted with either ATP or magnesium-free buffer, a single protein was eluted as seen on a silver-stained SDS-PAGE gel (Fig. 7) . This the SAM from A. actinomycetemcomitans showed the presence of the specific 62-kD antigen in this surface-associated fraction (Fig. 8 ).
Bone-resorbing activity of other bacterial GroEL-like proteins. The GroEL-like proteins from M. leprae and M. tuberculosis (i.e., hsp 60) and E. coli GroEL, when Western immunoblotted, reacted with antibody P3 (Fig. 8) , showing that these proteins shared the epitope which P3 recognized and which was associated with the inhibition of the bone-resorbing activity. However, when these various purified proteins were tested for activity in the calvarial bone resorption assay only that from E. coli had the capacity to stimulate resorption after removal of associated LPS (Fig. 9) . LPS removal was confirmed by run- ning the GroEL preparations on overloaded SDS-PAGE and silver staining the gels to look for the characteristic LPS ladder pattern.
Role of LPS. The possibility that the osteolytic activity of the SAM was due to either LPS contamination or synergy between LPS and the GroEL homologue was addressed. The starting material (SAM) had low levels of endotoxin, and silverstained SDS-PAGE gels overloaded with the purified GroEL homologue failed to show the ladder pattern characteristic of LPS (Fig. 10) . Polymyxin B inhibited the bone-resorbing activity of the LPS from A. actinomycetemcomitans but failed to inhibit the osteolytic activity of the purified GroEL homologue from this bacterium (Table III) . In contrast, antibody P3 inhibited the osteolytic activity of the GroEL homologue but failed to inhibit the activity of the LPS from A. actinomycetemcomitans (Table III) . In addition, the osteolytic activity of the GroEL homologue was sensitive both to heating and to trypsin (Table  Ill) . SAM and LPS from A. actinomycetemcomitans were also tested in the calvarial assay using C3H/HeJ mice which are unresponsive to LPS. The combined results from two separate experiments are shown in Table IV , which shows clearly that while the calvarial bone is responsive to the SAM it is unresponsive to the LPS from this organism.
To ascertain if LPS and GroEL interacted in a synergistic manner in the bone resorption assay, suboptimal concentrations of both components were added singly or together to calvaria and the amount of bone resorption was determined 48 h later. No evidence of synergistic interactions was noted, indeed the two components failed to produce an additive response (Table V) .
Discussion
LUP is characterized by the severe and rapid loss of alveolar bone on the approximal surfaces of first molar and/or incisor teeth and is generally associated with the presence of the Gramnegative bacterium A. actinomycetemcomitans (1, 2). Work from the Eastman Dental Institute has established that gentle saline extraction of this organism releases a proteinaceous fraction that is assumed to be associated with the external surface of the outer membrane. Electron microscopic examination of bacteria after extraction failed to show evidence of cell disruption (5, 6) . The finding of extremely low LPS levels in the SAM is additional evidence of the lack of postextraction cell lysis. Of course it cannot be conclusively proven that all proteins in the SAM come from the cell surface and the term is therefore (27) , the bone-resorbing activity of the SAM from A. actinomycetemcomitans cannot be inhibited by nonsteroidal antiinflammatory drugs or by inhibiting the actions of the potent osteolytic cytokines IL-I or TNFa (6) . Thus the active component in the SAM appears not to be able to induce key mediators normally associated with the induction of calvarial bone resorption (4) . This suggests that the active moiety in the SAM is interacting directly with bone cells to induce resorption. Our preliminary studies suggest that the active protein can directly stimulate the recruitment of the primary bone-resorbing cell (the osteoclast), but we cannot rule out a direct effect on osteoblasts (6) . A substantial degree of purification of the osteolytic activity of the SAM was achieved by anion exchange chromatography and activity appeared to be associated with a 62-kD protein.
Further purification, using anion exchange chromatography, failed to isolate the active protein to homogeneity. We had shown previously that sera from a proportion of patients with UP could block the osteolytic activity of the SAM from A. actinomycetemcomitans (28) and we had begun a program to develop and test monoclonal antibodies to the SAM to both aid purification and to provide probes for studies of the biological activity of this material. Two antibodies were found that inhibited the SAM-induced resorption of bone, and one of these antibodies, P3, was able to remove the bone-resorbing activity by immunoabsorption. In contrast, normal mouse serum or mAbs PI and A5 (which are of the same IgG1 subclass as mAbs P2 and P3) had no inhibitory activity. When antibodies P2 and P3 were used in Western blots to identify the antigen, (Table II) . Electron microscopic examination of negatively stained preparations of this A. actinomycetemcomitans GroEL-like protein showed the characteristic double ring structure with sevenfold symmetry (25) (our unpublished data). We conclude that the surface-associated material from the oral bacterium A. actinomycetemcomitans contains a homologue of the E. coli molecular chaperone or heat shock protein, GroEL, and that this protein is responsible for the potent bone-resorbing activity of this fraction. When the purified GroEL homologue was run through a TSK250 gel filtration column that had a molecular exclusion limit of 300 kD, the boneresorbing activity appeared in the void volume, implying that the GroEL multimer is the active moiety. The (28) .
The GroEL homologue is a potent stimulator of bone resorption with some preparations of SAM demonstrating bone-resorbing activity at a concentration of 1 ng/ml. We have now established that the active protein has a molecular mass of 62 kD and that it represents -2% of the dry mass of the SAM. Thus, this protein is capable of demonstrating bone-resorbing activity at a molar concentration of -1 pM, a similar potency to that of the most active bone-stimulating agonist, .
That the osteolytic activity was due to contaminating LPS, or to some interaction between LPS and the GroEL homologue, was a possibility that required investigation. The LPS content of the SAM and the GroEL has been determined by the Limulus assay and was low. One of the authors (T. Nishihara) has shown that the LPS from A. actinomycetemcomitans has comparable activity to that of E. coli LPS in the Limulus assay (34) . A. actinomycetemcomitans LPS produces a classic ladder pattern on silver-stained SDS-PAGE gels (34) . No such ladder pattern was seen on an overloaded silver-stained SDS-PAGE gel of the purified GroEL homologue. Thus, it would appear that LPS contamination is minimal. It was further shown that while the osteolytic activity of the LPS from A. actinomycetemcomitans could be inhibited by polymyxin B, that of the SAM or the purified GroEL homologue was unaffected. In contrast, the neutralizing mAb P3 had no inhibitory effect on the bone-resorbing activity of LPS. It was also demonstrated that calvaria from the LPS-unresponsive mouse strain C3H/HeJ would resorb in response to the SAM but not when stimulated with the LPS from A. actinomycetemcomitans, confirming that the osteolytic activity in the SAM was not due to LPS contamination. The biological effects of LPS are not sensitive to heat or trypsin, yet the bone-resorbing activity of the SAM and the GroEL was significantly inhibited by short-term heating or exposure to trypsin. These findings refute the hypothesis that the boneresorbing activity is due to LPS. It was possible that residual LPS in the SAM could form a complex with the GroEL homologue that demonstrated the property of synergism. This possibility was tested by adding suboptimal concentrations of LPS or GroEL to bone. However, this showed no evidence of synergy and indeed suggested that both components could possibly interfere with each other in inducing bone resorption. Thus, we conclude that the osteolytic effects of the SAM are due to the activity of a GroEL-like chaperone protein and that LPS plays no part in the activity.
We have examined the bone-resorbing activity of GroEL from E. coli and GroEL homologues from M. tuberculosis and M. leprae and have found that the former does indeed demonstrate osteolytic activity but that the latter two (once the LPS has been removed) have little bone-resorbing activity. This difference in osteolytic activity may be due to structural differences in these GroEL proteins, and further studies are underway to clone and sequence the GroEL homologue from A. actinomycetemcomitans.
We therefore speculate that the GroEL homologue of A. actinomycetemcomitans functions both as a bone-resorbing virulence factor and as an immunogen. In a proportion of patients, the immune response to this protein is neutralizing, and we are currently setting up studies to determine if this neutralizing immune response plays any role in the clinical course of the bone destruction.
